glp-1 obesity drug news today september 15 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Dosing looks nearly identical, both once-a-week shots on similar step-up schedules

Drug Reactions BPC-157 has been shown to reduce the adverse effects of NSAIDs, psychiatric drugs, and several cardiac treatments

If there are issues, simple lifestyle changes or supplements containing antioxidants like CoQ10 and L-carnitine can help [10]

You can call the healthdirect helpline on 1800 022 222 (known as NURSE-ON-CALL in Victoria)

Tablets are free of caffeine and have no added sugar

Triggers for initiating a discussion on switching may include HbA 1c targets not being met, the need for additional weight loss, patients moving to an increased cardiovascular risk status and poor adherence